Showing results (291-300 of 861) with videos related to

Sort By:
Pageof 87
Neurology|July 10, 2013
Mortality in patients with multiple sclerosisAntonio Scalfari, Volker Knappertz, Gary Cutter, et al.
Neurology|October 27, 2020
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple SclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
European Journal of Neurology|January 15, 2021
Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?Marcus W Koch, Jop Mostert, Pavle Repovic, et al.
Frontiers in Cellular and Infection Microbiology|February 19, 2024
Antibody responses to Chlamydia trachomatis vaccine candidate antigens in Chlamydia-infected women and correlation with antibody-mediated phagocytosis of elementary bodiesHong Yu, William M Geisler, Chuanbin Dai, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Considerations for an Adaptive Design for a Serious Rare DiseaseKaushik Patra, Bruce A C Cree, Eliezer Katz, et al.
Pediatric Dermatology|June 5, 2007
Randomized trial on sun safety education at ski and snowboard schools in western North AmericaBarbara Walkosz, Jenifer Voeks, Peter Andersen, et al.
Multiple Sclerosis and Related Disorders|May 1, 2022
Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseasesLucia Saidenberg, Arnaldo A Arbini, Gregg J Silverman, et al.
Nature Reviews. Neurology|July 31, 2013
Treatment trials in progressive MS--current challenges and future directionsMarcus W Koch, Gary Cutter, Peter K Stys, et al.
Journal of Child Neurology|December 17, 2017
Neurofibromatosis Clinical Trial ConsortiumRoger J Packer, Michael J Fisher, Gary Cutter, et al.
JMIR Research Protocols|May 2, 2019
An Intervention for Changing Sedentary Behavior Among African Americans With Multiple Sclerosis: ProtocolJessica F Baird, Jeffer Eidi Sasaki, Brian M Sandroff, et al.
Pageof 87